JAN GARFINKLE

Jan Garfinkle stands as a prominent figure in the healthcare venture capital landscape, serving as a co-founder and Managing Director at Arboretum Ventures. Based in Ann Arbor, Michigan, Arboretum Ventures is renowned for its strategic investments in early-stage healthcare companies, and Jan Garfinkle's leadership has been instrumental in shaping its success and investment philosophy.

At Arboretum Ventures, Jan Garfinkle plays a pivotal role in identifying and nurturing groundbreaking companies that aim to transform healthcare. Her investment focus spans critical areas including healthcare information technology (IT), medical devices, diagnostics, and healthcare services. She is particularly adept at recognizing opportunities where innovative technologies and business models can address significant unmet clinical needs, improve patient outcomes, and enhance efficiency within the healthcare system. Her approach emphasizes capital efficiency, strong management teams, and clear pathways for regulatory approval and market adoption.

Jan Garfinkle's extensive career background provides a robust foundation for her investment acumen. She earned her Bachelor of Science in Engineering from the University of Michigan and an MBA from the Wharton School at the University of Pennsylvania. Prior to co-founding Arboretum Ventures in 1999, she gained invaluable operational experience in the medical device industry. Her tenure at Guidant Corporation (now part of Boston Scientific and Abbott) involved significant roles in product development and marketing, giving her a deep understanding of the challenges and opportunities in bringing medical innovations to market. This blend of engineering, business, and industry experience uniquely positions her to evaluate complex healthcare technologies and guide entrepreneurial teams.

Throughout her career at Arboretum Ventures, Jan Garfinkle has been involved in numerous successful investments that have made a tangible impact on healthcare. Notable investments include companies like Accuri Cytometers (acquired by Becton Dickinson), HealthMedia (acquired by Johnson & Johnson), and NeuMoDx (acquired by QIAGEN). These examples highlight her ability to spot promising ventures and support their growth from nascent stages to successful exits, delivering both financial returns and significant advancements in patient care. Her commitment extends beyond capital, offering strategic guidance and mentorship to portfolio companies, helping them navigate the intricate healthcare ecosystem.

Jan Garfinkle's vision and dedication continue to drive innovation in healthcare. Her work at Arboretum Ventures not only fosters the growth of cutting-edge companies but also contributes to the broader mission of improving health outcomes globally. She remains a respected voice in the venture capital community, advocating for thoughtful investment in technologies that promise a healthier future.